That study was the first to elucidate a role of the TF in the AR–TGF-β axis, which could provide another explanation for the common clinical problem of metastatic CRPC developing after a standard ADT regimen in PCa patients. This evidence concerns the gene TGFB1 and posterior cortical atrophy.